Catabasis Pharma (CATB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | CATB | ESLA | CLNN | ||
Company | Catabasis Pharma | Estrella Immunopharma Inc | Clene Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 9.21 | 0.9300 | 5.15 | ||
High | 9.21 | 1.0000 | 5.29 | ||
Low | 8.46 | 0.9300 | 4.92 | ||
Last | 8.54 | 0.9301 | 5.18 | ||
Change | -0.64 | +0.0001 | +0.16 | ||
% Change | -6.97% | +0.01% | +3.19% | ||
Volume | 98,800 | 6,038 | 102,432 | ||
20-Day Average Volume | 395,311 | 21,235 | 88,860 | ||
Previous Close | 9.18 | 0.9300 | 5.02 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | No | Yes | ||
Technicals | |||||
20-Day Moving Average | 8.72 | 1.0970 | 5.74 | ||
20-Day Raw Stochastic | 56.46% | 11.94% | 14.43% | ||
20-Day Relative Strength | 43.24% | 40.88% | 46.36% | ||
Weighted Alpha | -50.43 | -66.81 | -55.65 | ||
Today's Opinion | 88% Sell | 40% Sell | 64% Sell | ||
Previous Opinion | 72% Sell | 40% Sell | 80% Sell | ||
Last Month's Opinion | 100% Sell | 72% Buy | 88% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -14.34% since 08/31/21 | -21.18% since 09/12/24 | -18.30% since 09/12/24 | ||
Low | 8.46 on 09/08/21 | 0.8973 on 09/17/24 | 4.89 on 09/18/24 | ||
High | 10.26 on 09/02/21 | 1.2000 on 09/13/24 | 6.83 on 09/16/24 | ||
1-Month | |||||
%Chg | -8.17% since 08/06/21 | -33.09% since 08/19/24 | -2.26% since 08/19/24 | ||
Low | 6.31 on 08/20/21 | 0.8718 on 09/11/24 | 4.89 on 09/18/24 | ||
High | 10.26 on 09/02/21 | 1.4200 on 08/21/24 | 6.90 on 09/05/24 | ||
3-Month | |||||
%Chg | -34.10% since 06/08/21 | +14.54% since 06/18/24 | -31.86% since 06/18/24 | ||
Low | 6.31 on 08/20/21 | 0.8221 on 06/24/24 | 3.82 on 08/05/24 | ||
High | 15.72 on 06/16/21 | 3.2300 on 07/26/24 | 8.20 on 06/21/24 | ||
6-Month | |||||
%Chg | -50.23% since 03/08/21 | -15.45% since 03/19/24 | -35.43% since 03/19/24 | ||
Low | 6.31 on 08/20/21 | 0.8100 on 06/18/24 | 3.82 on 08/05/24 | ||
High | 22.01 on 03/18/21 | 3.2300 on 07/26/24 | 9.20 on 06/07/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 33,337 | 33,830 | 32,237 | ||
Shares Outstanding, K | 3,904 | 36,376 | 6,422 | ||
Annual Sales | 0 | 0 | 650,000 | ||
Annual Net Income | -37,300,000 | -80,000 | -49,500,000 | ||
Last Quarter Sales | 0 | 0 | 90,000 | ||
Last Quarter Net Income | -7,470,000 | -470,000 | -6,790,000 | ||
60-Month Beta | 1.66 | 0.18 | 0.49 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | -0.01 on 05/14/24 | -1.06 on 08/07/24 | ||
Latest Earnings Date | 08/09/21 | 09/24/24 | 11/05/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |